title: Hyperprolactinemia as a rare cause of hypertension in chronic renal failure.
abstract: Chronic renal failure (CRF) is associated with a high risk for hypertension. An individualized treatment should be initiated after the diagnosis of hypertension and underlying etiology. Many metabolic and endocrinal abnormalities are encountered in CRF. We present an 11-year-old boy with CRF developing galactorrhea and hyperprolactinemia associated with α-methyldopa, defective dopaminergic control, and resistance to multi-antihypertensive therapy. Cabergoline, a dopamine receptor agonist, was effectively used in the treatment of hypertension. It is important to remember that sometimes treatment of an illness becomes the cause of this illness.
authors.affiliation: Department of Pediatric Nephrology, Baskent University, Ankara, Turkey. kaangulleroglu@yahoo.com
authors.forename: Kaan
authors.initials: K
authors.lastname: Gulleroglu
authors.forename: Asburce
authors.initials: A
authors.lastname: Olgac
authors.forename: Umut
authors.initials: U
authors.lastname: Bayrakci
authors.forename: Ozlem
authors.initials: O
authors.lastname: Erdogan
authors.forename: Sibel Tulgar
authors.initials: ST
authors.lastname: Kinik
authors.forename: Esra
authors.initials: E
authors.lastname: Baskin
mesh_terms: D002648:Child; D005687:Galactorrhea / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D006966:Hyperprolactinemia / Q000150:complications* / Q000188:drug therapy; D006973:Hypertension / Q000188:drug therapy / Q000209:etiology*; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000628:therapy; D008297:Male; D006435:Renal Dialysis / Q000009:adverse effects*